TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT05292794: Use of CereGate Therapy for Freezing of Gait in PD

Sponsor: CereGate Inc. · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 41 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$1,280,400

Rescue Site Savings

+$853,600

Unlock Full NCT05292794 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05292794 Rescue Dossier →